verified that AKR1B10 was expressed predominantly in the cytoplasm of GC cells and that positive expression of AKR1B10 was associated with lymph node metastasis and poorer tumor response to neoadjuvant chemotherapy, which indicated a poorer prognosis for the patient (7, 46). The gene discussed is AKR1B10; the disease is neoplasm.